CASI Pharmaceuticals
CASI
#10630
Rank
A$5.95 M
Marketcap
A$0.29
Share price
0.00%
Change (1 day)
-89.83%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -A$73.7 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are A$26.84 Million. In 2024 the company made an earning of -A$53.15 Million a decrease over its 2023 earnings that were of -A$36.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$73.7 Million38.69%
2024 -A$53.15 Million44.35%
2023 -A$36.82 Million-29.55%
2022 -A$52.25 Million4.43%
2021 -A$50.04 Million-24.56%
2020 -A$66.33 Million4.74%
2019 -A$63.33 Million65.13%
2018 -A$38.35 Million155.07%
2017 -A$15.04 Million13.93%
2016 -A$13.2 Million31.18%
2015 -A$10.06 Million-72.5%
2014 -A$36.58 Million356.62%
2013 -A$8.02 Million-60.55%
2012 -A$20.31 Million218.41%
2011 -A$6.38 Million0.74%
2010 -A$6.33 Million-32.54%
2009 -A$9.39 Million-66.98%
2008 -A$28.42 Million-14.22%
2007 -A$33.13 Million7.04%
2006 -A$30.95 Million27.95%
2005 -A$24.19 Million4.51%
2004 -A$23.15 Million-15.84%
2003 -A$27.5 Million-55.29%
2002 -A$61.51 Million-34.05%
2001 -A$93.27 Million31.73%
2000 -A$70.8 Million31.56%
1999 -A$53.82 Million145.56%
1998 -A$21.92 Million76.4%
1997 -A$12.43 Million36.92%
1996 -A$9.08 Million